On the other hand, the clinical presentation of MAS is largely unchanged in mice with NLRC4 gain of function mutations, which in patients lead to hyper-IL-18 and recurrent MAS [77, 78], although notably these animals do not show free IL-18 elevation [37]. Here, IL18 is linked to macrophage activation syndrome.